99 related articles for article (PubMed ID: 16820939)
1. Efficient platelet delta-granule release induced by [Ca2+]i elevation is modulated by GPIIbIIIa.
Gobbi G; Sponzilli I; Mirandola P; Tazzari PL; Caimi L; Cacchioli A; Matteucci A; Giuliani Piccari G; Cocco L; Vitale M
Int J Mol Med; 2006 Aug; 18(2):309-13. PubMed ID: 16820939
[TBL] [Abstract][Full Text] [Related]
2. Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry.
Bryant AE; Bayer CR; Hayes-Schroer SM; Stevens DL
J Infect Dis; 2003 Feb; 187(3):408-17. PubMed ID: 12552424
[TBL] [Abstract][Full Text] [Related]
3. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
4. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
[TBL] [Abstract][Full Text] [Related]
5. Type I Glanzmann thrombasthenia: most common subtypes in North Indians.
Kannan M; Ahmed RP; Jain P; Kumar R; Choudhry VP; Saxena R
Am J Hematol; 2003 Oct; 74(2):139-41. PubMed ID: 14508803
[TBL] [Abstract][Full Text] [Related]
6. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
8. A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia.
Vijapurkar M; Ghosh K; Shetty S; McLane MA; Moura da Silva AM; Butera D
Haematologica; 2008 May; 93(5):797-8. PubMed ID: 18450741
[No Abstract] [Full Text] [Related]
9. Acquired thrombasthenia due to GPIIbIIIa platelet autoantibodies in a 4-yr-old child.
Bloor AJ; Smith GA; Jaswon M; Parker NE; Ouwehand WH; Liesner R
Eur J Haematol; 2006 Jan; 76(1):89-90. PubMed ID: 16343278
[No Abstract] [Full Text] [Related]
10. Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP.
Kim JM; Koo YK; Heo JE; Park S; Yun-Choi HS
Thromb Res; 2009 May; 124(1):90-5. PubMed ID: 19232685
[TBL] [Abstract][Full Text] [Related]
11. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa and P2Y12 induction by oligochitosan accelerates platelet aggregation.
Periayah MH; Halim AS; Yaacob NS; Saad AZ; Hussein AR; Rashid AH; Ujang Z
Biomed Res Int; 2014; 2014():653149. PubMed ID: 25247182
[TBL] [Abstract][Full Text] [Related]
14. Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiol-containing proteins.
Badol P; David-Dufilho M; Auger J; Whiteheart SW; Rendu F
Platelets; 2007 Nov; 18(7):481-90. PubMed ID: 17852771
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
[TBL] [Abstract][Full Text] [Related]
16. AFM measurements of interactions between the platelet integrin receptor GPIIbIIIa and fibrinogen.
Agnihotri A; Soman P; Siedlecki CA
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):138-47. PubMed ID: 19250806
[TBL] [Abstract][Full Text] [Related]
17. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase.
Otterdal K; Pedersen TM; Solum NO
Thromb Res; 2004; 114(3):167-77. PubMed ID: 15342213
[TBL] [Abstract][Full Text] [Related]
18. A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders.
Mumford AD; Frelinger AL; Gachet C; Gresele P; Noris P; Harrison P; Mezzano D
Thromb Haemost; 2015 Jul; 114(1):14-25. PubMed ID: 25879272
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation in patients with systemic scleroderma--pattern and significance.
Agache I; Rădoi M; Duca L
Rom J Intern Med; 2007; 45(2):183-91. PubMed ID: 18333373
[TBL] [Abstract][Full Text] [Related]
20. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene.
Bryant AE; Chen RY; Nagata Y; Wang Y; Lee CH; Finegold S; Guth PH; Stevens DL
J Infect Dis; 2000 Sep; 182(3):808-15. PubMed ID: 10950775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
